Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND
ISSUER PURCHASES OF EQUITY SECURITIES
Our common stock currently trades on the New York Stock Exchange under the symbol “NGS”. As of December 31, 2023, as reflected by our transfer agent records, we had 7 record holders of our common stock. This number does not include any beneficial owners for whom shares of common stock may be held in “nominee” or “street” name. On March 28, 2024, the last reported sale price of our common stock as reported by the New York Stock Exchange was $19.43 per share.
Dividends
To date, we have not declared or paid any dividends on our common stock. We currently do not anticipate paying a cash dividend on our common stock. Although we intend to retain our earnings, if any, to finance the growth of our business, our Board of Directors will have the discretion to declare and pay dividends in the future. Payment of dividends in the future
22
will depend upon our earnings, capital requirements, and other factors which our Board of Directors may deem relevant. Our credit agreement also contains restrictions on our paying dividends under certain circumstances.
Equity Compensation Plans
The following table summarizes certain information regarding our equity compensation plans as of December 31, 2023:
Plan Category
(a)
Number of securities to vest or be issued upon exercise of outstanding options
(b)
Weighted-average
issuance or exercise price of
outstanding options
(c)
Number of securities remaining available for future issuance under equity compensation plans
(excluding securities reflected in column (a))
Equity compensation plans approved by security holders:
Stock Option Plan 129,751 (1) $ 20.59 415,085
2019 Equity Incentive Plan 133,898 $ 10.66 405,833
Total 263,649 820,918
(1) Total number of shares issuable upon exercise of options granted to employees, officers, and directors under our 1998 Stock Option Plan.
Sale of Unregistered Securities and Issuer Repurchases
We made no sales of unregistered securities during the year ended December 31, 2023, nor any repurchases during 2023.
23
ITEM 6. RESERVED
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.